ciprofloxacin has been researched along with taurolidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gurkan, T; Oguz, E; Oguz, H; Ozbilge, H | 1 |
| Boger, MS; Collins, CA; Mason, L; Raad, II; Sherertz, RJ | 1 |
2 other study(ies) available for ciprofloxacin and taurolidine
| Article | Year |
|---|---|
Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Cornea; Disease Models, Animal; Eye Infections, Bacterial; Keratitis; Ofloxacin; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Taurine; Thiadiazines | 2005 |
Comparative in vitro efficacies of various catheter lock solutions.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anticoagulants; Candida albicans; Catheterization; Catheters, Indwelling; Ciprofloxacin; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Edetic Acid; Ethanol; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Pharmaceutical Preparations; Pseudomonas aeruginosa; Rifampin; Solutions; Staphylococcus aureus; Staphylococcus epidermidis; Taurine; Thiadiazines; Time Factors; Vancomycin | 2006 |